CN113683572A - Intermediate of oxadegril and preparation method and application thereof - Google Patents
Intermediate of oxadegril and preparation method and application thereof Download PDFInfo
- Publication number
- CN113683572A CN113683572A CN202010421962.XA CN202010421962A CN113683572A CN 113683572 A CN113683572 A CN 113683572A CN 202010421962 A CN202010421962 A CN 202010421962A CN 113683572 A CN113683572 A CN 113683572A
- Authority
- CN
- China
- Prior art keywords
- compound
- reaction
- added
- stirred
- organic phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- 150000001875 compounds Chemical class 0.000 claims abstract description 99
- 238000000034 method Methods 0.000 claims abstract description 22
- 238000010438 heat treatment Methods 0.000 claims description 31
- 239000000543 intermediate Substances 0.000 claims description 27
- JCKZNMSBFBPDPM-UHFFFAOYSA-N (2-fluoro-3-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1F JCKZNMSBFBPDPM-UHFFFAOYSA-N 0.000 claims description 21
- 239000003054 catalyst Substances 0.000 claims description 21
- 229940125898 compound 5 Drugs 0.000 claims description 21
- 125000000217 alkyl group Chemical group 0.000 claims description 19
- 238000006482 condensation reaction Methods 0.000 claims description 17
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 16
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 14
- 229940125904 compound 1 Drugs 0.000 claims description 12
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical group BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 9
- 229910052794 bromium Inorganic materials 0.000 claims description 9
- 229940126214 compound 3 Drugs 0.000 claims description 9
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 8
- 239000000460 chlorine Substances 0.000 claims description 8
- 229910052801 chlorine Inorganic materials 0.000 claims description 8
- 239000011630 iodine Chemical group 0.000 claims description 8
- 229910052740 iodine Chemical group 0.000 claims description 8
- 238000007363 ring formation reaction Methods 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 7
- RINUERVPFANASB-UHFFFAOYSA-N 2-(bromomethyl)-1-fluoro-3-(trifluoromethyl)benzene Chemical compound FC1=CC=CC(C(F)(F)F)=C1CBr RINUERVPFANASB-UHFFFAOYSA-N 0.000 claims description 6
- 125000003342 alkenyl group Chemical group 0.000 claims description 6
- 125000000304 alkynyl group Chemical group 0.000 claims description 6
- 230000009471 action Effects 0.000 claims description 4
- 239000003513 alkali Substances 0.000 claims description 4
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 claims description 3
- 238000006069 Suzuki reaction reaction Methods 0.000 claims description 3
- FZFAMSAMCHXGEF-UHFFFAOYSA-N chloro formate Chemical compound ClOC=O FZFAMSAMCHXGEF-UHFFFAOYSA-N 0.000 claims description 2
- 229940125782 compound 2 Drugs 0.000 claims description 2
- 238000005580 one pot reaction Methods 0.000 claims description 2
- KZNICNPSHKQLFF-UHFFFAOYSA-N succinimide Chemical class O=C1CCC(=O)N1 KZNICNPSHKQLFF-UHFFFAOYSA-N 0.000 claims description 2
- 238000005903 acid hydrolysis reaction Methods 0.000 claims 1
- 125000004442 acylamino group Chemical group 0.000 claims 1
- 230000002140 halogenating effect Effects 0.000 claims 1
- 229940117803 phenethylamine Drugs 0.000 claims 1
- 238000006243 chemical reaction Methods 0.000 abstract description 202
- 239000002994 raw material Substances 0.000 abstract description 35
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 238000005265 energy consumption Methods 0.000 abstract description 2
- 238000013341 scale-up Methods 0.000 abstract description 2
- 239000002699 waste material Substances 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 127
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 124
- 239000012074 organic phase Substances 0.000 description 90
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 78
- 238000003756 stirring Methods 0.000 description 68
- 239000000243 solution Substances 0.000 description 64
- 239000007787 solid Substances 0.000 description 51
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 45
- JMMWKPVZQRWMSS-UHFFFAOYSA-N isopropanol acetate Natural products CC(C)OC(C)=O JMMWKPVZQRWMSS-UHFFFAOYSA-N 0.000 description 45
- 229940011051 isopropyl acetate Drugs 0.000 description 45
- GWYFCOCPABKNJV-UHFFFAOYSA-N isovaleric acid Chemical compound CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 45
- 239000000203 mixture Substances 0.000 description 44
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 44
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical group [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 38
- 238000005160 1H NMR spectroscopy Methods 0.000 description 34
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 33
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 33
- 239000007858 starting material Substances 0.000 description 33
- 239000000706 filtrate Substances 0.000 description 32
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 31
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 28
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 28
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 27
- 239000012046 mixed solvent Substances 0.000 description 27
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 26
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical class [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 25
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 24
- 238000001914 filtration Methods 0.000 description 22
- 229910000160 potassium phosphate Inorganic materials 0.000 description 22
- 235000011009 potassium phosphates Nutrition 0.000 description 22
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 21
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 20
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 19
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 19
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 19
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 19
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 18
- 239000008213 purified water Substances 0.000 description 18
- 238000001704 evaporation Methods 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 15
- 229910000027 potassium carbonate Inorganic materials 0.000 description 14
- 235000011181 potassium carbonates Nutrition 0.000 description 14
- 238000000926 separation method Methods 0.000 description 14
- 229910000029 sodium carbonate Inorganic materials 0.000 description 13
- 235000017550 sodium carbonate Nutrition 0.000 description 13
- -1 (R) -tert-butyl (2-amino-1-phenylethyl) amino carbonate Chemical compound 0.000 description 12
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 12
- PCLIMKBDDGJMGD-UHFFFAOYSA-N N-bromosuccinimide Chemical compound BrN1C(=O)CCC1=O PCLIMKBDDGJMGD-UHFFFAOYSA-N 0.000 description 12
- JRNVZBWKYDBUCA-UHFFFAOYSA-N N-chlorosuccinimide Chemical compound ClN1C(=O)CCC1=O JRNVZBWKYDBUCA-UHFFFAOYSA-N 0.000 description 12
- LQZMLBORDGWNPD-UHFFFAOYSA-N N-iodosuccinimide Chemical compound IN1C(=O)CCC1=O LQZMLBORDGWNPD-UHFFFAOYSA-N 0.000 description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 12
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 12
- 238000012544 monitoring process Methods 0.000 description 12
- 239000003921 oil Substances 0.000 description 12
- 239000011541 reaction mixture Substances 0.000 description 12
- 229910001873 dinitrogen Inorganic materials 0.000 description 11
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 10
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000001301 oxygen Substances 0.000 description 10
- 229910052760 oxygen Inorganic materials 0.000 description 10
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 10
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 238000005406 washing Methods 0.000 description 9
- 238000001816 cooling Methods 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 150000007529 inorganic bases Chemical class 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- 239000008346 aqueous phase Substances 0.000 description 7
- 150000007530 organic bases Chemical class 0.000 description 7
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 6
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical group OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 6
- 230000005587 bubbling Effects 0.000 description 6
- 230000005494 condensation Effects 0.000 description 6
- 239000012043 crude product Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000002002 slurry Substances 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-diisopropylethylamine Substances CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 5
- 239000012295 chemical reaction liquid Substances 0.000 description 5
- 239000007810 chemical reaction solvent Substances 0.000 description 5
- 238000006392 deoxygenation reaction Methods 0.000 description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- 201000009273 Endometriosis Diseases 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 4
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 4
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 4
- 238000009833 condensation Methods 0.000 description 4
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 4
- 239000002808 molecular sieve Substances 0.000 description 4
- 239000011736 potassium bicarbonate Substances 0.000 description 4
- 235000015497 potassium bicarbonate Nutrition 0.000 description 4
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 4
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 4
- 235000011118 potassium hydroxide Nutrition 0.000 description 4
- 239000001632 sodium acetate Substances 0.000 description 4
- 235000017281 sodium acetate Nutrition 0.000 description 4
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000001308 synthesis method Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 3
- HEAUOKZIVMZVQL-VWLOTQADSA-N Elagolix Chemical compound COC1=CC=CC(C=2C(N(C[C@H](NCCCC(O)=O)C=3C=CC=CC=3)C(=O)N(CC=3C(=CC=CC=3F)C(F)(F)F)C=2C)=O)=C1F HEAUOKZIVMZVQL-VWLOTQADSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 239000002585 base Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- YPMPTULBFPFSEQ-PLNGDYQASA-N ethyl (z)-3-aminobut-2-enoate Chemical compound CCOC(=O)\C=C(\C)N YPMPTULBFPFSEQ-PLNGDYQASA-N 0.000 description 3
- 150000007522 mineralic acids Chemical class 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- AHWALFGBDFAJAI-UHFFFAOYSA-N phenyl carbonochloridate Chemical compound ClC(=O)OC1=CC=CC=C1 AHWALFGBDFAJAI-UHFFFAOYSA-N 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- OGQYJDHTHFAPRN-UHFFFAOYSA-N 2-fluoro-6-(trifluoromethyl)benzonitrile Chemical compound FC1=CC=CC(C(F)(F)F)=C1C#N OGQYJDHTHFAPRN-UHFFFAOYSA-N 0.000 description 2
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 2
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- UORVGPXVDQYIDP-UHFFFAOYSA-N borane Chemical compound B UORVGPXVDQYIDP-UHFFFAOYSA-N 0.000 description 2
- 230000031709 bromination Effects 0.000 description 2
- 238000005893 bromination reaction Methods 0.000 description 2
- 229960001701 chloroform Drugs 0.000 description 2
- 239000002274 desiccant Substances 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 229950004823 elagolix Drugs 0.000 description 2
- 210000005168 endometrial cell Anatomy 0.000 description 2
- 229940093499 ethyl acetate Drugs 0.000 description 2
- 239000012065 filter cake Substances 0.000 description 2
- 238000005658 halogenation reaction Methods 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 description 2
- 229940098779 methanesulfonic acid Drugs 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 210000003101 oviduct Anatomy 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- RNHDAKUGFHSZEV-UHFFFAOYSA-N 1,4-dioxane;hydrate Chemical compound O.C1COCCO1 RNHDAKUGFHSZEV-UHFFFAOYSA-N 0.000 description 1
- IBXMKLPFLZYRQZ-UHFFFAOYSA-N 1,5-diphenylpenta-1,4-dien-3-one;palladium Chemical compound [Pd].[Pd].C=1C=CC=CC=1C=CC(=O)C=CC1=CC=CC=C1 IBXMKLPFLZYRQZ-UHFFFAOYSA-N 0.000 description 1
- JIXDOBAQOWOUPA-UHFFFAOYSA-N 1-fluoro-2-methoxybenzene Chemical compound COC1=CC=CC=C1F JIXDOBAQOWOUPA-UHFFFAOYSA-N 0.000 description 1
- ANEXTOPWMYHSDQ-UHFFFAOYSA-N 2-methoxy-9,10-dihydrophenanthren-4-ol Chemical compound COC1=CC=2CCC3=CC=CC=C3C2C(=C1)O ANEXTOPWMYHSDQ-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 1
- 238000007126 N-alkylation reaction Methods 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000000450 Pelvic Pain Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- ZRNSOMJORQIGNW-UHFFFAOYSA-N acetic acid;2-phenylethanamine Chemical compound CC(O)=O.NCCC1=CC=CC=C1 ZRNSOMJORQIGNW-UHFFFAOYSA-N 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 229910000085 borane Inorganic materials 0.000 description 1
- UWTDFICHZKXYAC-UHFFFAOYSA-N boron;oxolane Chemical compound [B].C1CCOC1 UWTDFICHZKXYAC-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- YNHIGQDRGKUECZ-UHFFFAOYSA-N dichloropalladium;triphenylphosphanium Chemical compound Cl[Pd]Cl.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1[PH+](C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-N 0.000 description 1
- WYACBZDAHNBPPB-UHFFFAOYSA-N diethyl oxalate Chemical compound CCOC(=O)C(=O)OCC WYACBZDAHNBPPB-UHFFFAOYSA-N 0.000 description 1
- WASQWSOJHCZDFK-UHFFFAOYSA-N diketene Chemical compound C=C1CC(=O)O1 WASQWSOJHCZDFK-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 150000002081 enamines Chemical class 0.000 description 1
- XIMFCGSNSKXPBO-UHFFFAOYSA-N ethyl 2-bromobutanoate Chemical compound CCOC(=O)C(Br)CC XIMFCGSNSKXPBO-UHFFFAOYSA-N 0.000 description 1
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000002474 gonadorelin antagonist Substances 0.000 description 1
- 229940121381 gonadotrophin releasing hormone (gnrh) antagonists Drugs 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 208000000509 infertility Diseases 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 231100000535 infertility Toxicity 0.000 description 1
- 230000000622 irritating effect Effects 0.000 description 1
- XKORCTIIRYKLLG-ARJAWSKDSA-N methyl (z)-3-aminobut-2-enoate Chemical compound COC(=O)\C=C(\C)N XKORCTIIRYKLLG-ARJAWSKDSA-N 0.000 description 1
- QAWFLJGZSZIZHO-UHFFFAOYSA-N methyl 4-bromobutanoate Chemical compound COC(=O)CCCBr QAWFLJGZSZIZHO-UHFFFAOYSA-N 0.000 description 1
- XMJHPCRAQCTCFT-UHFFFAOYSA-N methyl chloroformate Chemical compound COC(Cl)=O XMJHPCRAQCTCFT-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- PIBWKRNGBLPSSY-UHFFFAOYSA-L palladium(II) chloride Chemical compound Cl[Pd]Cl PIBWKRNGBLPSSY-UHFFFAOYSA-L 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000004537 pulping Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009933 reproductive health Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000001291 vacuum drying Methods 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
The invention provides a novel method for preparing a key intermediate 1 of oxa-goril and simultaneously provides several novel intermediate compounds. Through the new intermediate and the preparation method, not only are the raw material and the synthesis cost greatly reduced, but also the yield is greatly improved. Meanwhile, the method has the advantages of low reaction energy consumption, less three wastes and mild reaction conditions, and is easy for industrial scale-up production.
Description
Technical Field
The invention relates to the technical field of intermediates of novel oral GnRH antagonist oxadegril and a synthesis method thereof.
Background
Endometriosis (EMs) refers to a common gynecological disease in women with intimal cells planted in abnormal locations. The endometrial cells should grow in the uterine cavity, but because the uterine cavity is communicated with the ovary and the pelvic cavity through the oviduct, the endometrial cells can enter the ovary, the pelvic cavity and the adjacent area of the uterus to grow ectopically through the oviduct. EMs are common clinical benign diseases of women in the childbearing age, the incidence rate of the diseases reaches 10.0%, and the diseases are in a remarkable rising trend, are mainly characterized by dysmenorrhea, pelvic pain and infertility, and seriously affect the reproductive health and the life quality of the women.
On 23/7/2018, the important product of erbavil, elagolix (loragol), was approved by the U.S. food and drug administration, which would be useful in treating pain due to EMs and became the first new oral drug for over 10 years for this indication, with a projected sale of $ 12.1 billion in 2022.
The chemical name of the oxa-rogle is as follows: 4- [ [ (1R) -2- [5- (2-fluoro-3-methoxyphenyl) -3- [ [ 2-fluoro-6- (trifluoromethyl) phenyl ] methyl ] -3, 6-dihydro-4-methyl-2, 6-dioxo-1 (2H) -pyrimidinyl ] -1-phenylethyl ] amino ] butanoic acid. WO2005007165A reports a synthesis method of oxa-rogue, in the route, 2-fluoro-6-trifluoromethyl benzonitrile is taken as a starting material, the 2-fluoro-6-trifluoromethyl benzonitrile is subjected to borane reduction, condensation with urea, cyclization with diethylenone and other steps in sequence to obtain an intermediate 1- [ 2-fluoro-6- (trifluoromethyl) benzyl ] -6-methylpyrimidine-2, 4(1H,3H) -diketone, the intermediate is subjected to bromination, amine alkylation and other steps, then subjected to Suzuki coupling reaction with 2-fluoro-3-methoxyphenylboronic acid, finally subjected to Boc protecting group removal to obtain a key intermediate compound 1, and subjected to condensation and hydrolysis reaction with 4-bromobutyric acid methyl ester to obtain the oxa-rogue. The synthetic route is as follows:
the synthetic route has the disadvantages of overlong steps, more complicated process, lower total yield, expensive starting materials, high risk of liquid bromine amplification production and high equipment requirement.
In the new synthesis method of the oxarogue, disclosed in the US patent 8765948B, o-fluoro anisole is used as a raw material, condensation with diethyl oxalate, reduction with sodium borohydride, bromination with lithium bromide and condensation with acetonitrile under the action of zinc powder are sequentially carried out to obtain an enamine intermediate, then amino is protected by phenyl chloroformate and undergoes cyclization reaction with (R) -tert-butyl (2-amino-1-phenylethyl) amino carbonate under the action of alkali to obtain a mother ring molecule, then the mother ring molecule and benzyl bromide intermediate complete N-alkylation reaction and undergo deprotection to obtain an oxarogue key intermediate 1, and the intermediate is subjected to condensation and hydrolysis reaction with 4-ethyl bromobutyrate to obtain the oxarogue. The synthetic route is as follows:
although the starting materials are simple and easy to obtain in the synthetic route, the reaction steps are long, a large amount of debrominated products are generated in the condensation process of bromide intermediates and acetonitrile, the yield is greatly reduced and is only 29.68%, and the scale-up production is severely limited.
Therefore, a method for synthesizing the loragoid, which has the advantages of improving the yield, reducing the cost and being suitable for industrial production, is still needed.
Disclosure of Invention
The invention aims to overcome the defects in the prior art and provide a novel method for preparing the loragolide in an industrial production mode.
Based on the new intermediate compound, the invention also provides a new intermediate compound for preparing the oxadegril and a preparation method of the new intermediate compound. Meanwhile, a novel preparation method of the existing key intermediate compound 1 is provided.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
novel compound 5 of the formula:
and R is selected from H and C1-C6 alkyl. Wherein alkyl is preferably methyl, ethyl, propyl, allyl, isopropyl, isobutyl or tert-butyl; further preferred is methyl, allyl, isopropyl, isobutyl or tert-butyl.
Novel compound 6 of the formula:
and R is selected from H and C1-C6 alkyl. Wherein alkyl is preferably methyl, ethyl, propyl, allyl, isopropyl, isobutyl or tert-butyl; further preferred is methyl, allyl, isopropyl, isobutyl or tert-butyl.
Novel compound 7 of the formula:
r is selected from H and alkyl of C1-C6, and X is selected from chlorine, bromine and iodine. Wherein alkyl is preferably methyl, ethyl, propyl, allyl, isopropyl, isobutyl or tert-butyl; further preferred is methyl, allyl, isopropyl, isobutyl or tert-butyl.
Novel compound 8 of the formula:
and R is selected from H or C1-C6 alkyl. Wherein alkyl is preferably methyl, ethyl, propyl, allyl, isopropyl, isobutyl or tert-butyl; further preferred is methyl, allyl, isopropyl, isobutyl or tert-butyl.
The preparation method of the new compound 5 comprises the following steps of carrying out condensation reaction on a compound 3 with a formula shown in the specification and R-alpha- (amido) phenylethylamine to obtain an intermediate compound 4, and carrying out cyclization reaction to obtain the new compound 5:
said R1Selected from C1-C12 substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl, and the like; and R is selected from H or C1-C6 alkyl. Said R1Preferably C1-C6 alkyl, more preferably ethyl or methyl; r is preferably methyl, ethyl, propyl, allyl, isopropyl, isobutyl or tert-butyl; further preferred is methyl, allyl, isopropyl, isobutyl or tert-butyl.
According to the method for preparing the compound 5, the compound 4 is obtained through condensation reaction, the compound 5 is obtained through cyclization reaction, the product 4 does not need to be separated in the middle, and the compound 5 can be obtained through direct heating and cyclization reaction in a one-pot method.
The above condensation reaction for preparing compound 5, wherein the base may be an inorganic base or an organic base, preferably an inorganic base. The inorganic base comprises sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide, lithium hydroxide, potassium phosphate, sodium acetate, disodium hydrogen phosphate, dipotassium hydrogen phosphate and the like, and preferably potassium carbonate; the organic base comprises triethylamine, N-diisopropylethylamine, pyridine, DBU and the like.
The condensation reaction for preparing the compound 5 as described above, wherein the reaction solvent is selected from the group consisting of toluene, 1, 4-dioxane, acetonitrile, N-dimethylformamide, N-dimethylacetamide, dimethylsulfoxide, N-methylpyrrolidone and the like, and N, N-dimethylformamide is preferred.
In the above method for preparing the compound 5, the compound 4 can be subjected to the cyclization reaction to obtain the compound 5 under room temperature conditions or under heating conditions, preferably at 20 to 150 ℃, and more preferably at 60 to 100 ℃.
The compound 3 adopted in the preparation method of the novel compound 5 is preferably obtained by using the preparation method provided by the invention, and the method is obtained by condensation reaction of a compound 2 with chloroformate:
said R1Selected from C1-C12 substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl and the like, wherein R is2Selected from substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl and the like selected from C1-C12. Said R1Preferably C1-C6 alkyl, more preferably ethyl or methyl; said R2The alkyl group is preferably a C1-C6 alkyl group, more preferably a methyl group, an ethyl group, a propyl group, an isopropyl group, an isobutyl group, a tert-butyl group, an allyl group, a vinyl group, an aryl group or the like, and still more preferably a phenyl group.
The above condensation reaction for preparing compound 3, the base may be an inorganic base or an organic base, preferably an organic base. The inorganic base comprises sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide, lithium hydroxide, potassium phosphate, sodium acetate, disodium hydrogen phosphate, dipotassium hydrogen phosphate and the like, and the organic base comprises triethylamine, N-diisopropylethylamine, pyridine, DBU and the like; pyridine is preferred.
In the condensation reaction for preparing the compound 3, when water is generated in the reaction process, a drying agent is required to be added, and the drying agent is selected from anhydrous sodium sulfate, anhydrous magnesium sulfate, calcium chloride, calcium oxide, a 4A molecular sieve and the like, and is preferably a 4A molecular sieve.
In the condensation reaction for producing the compound 3, the reaction solvent is selected from toluene, 1, 4-dioxane, acetonitrile, N-dimethylformamide, N-dimethylacetamide, dimethylsulfoxide, N-methylpyrrolidone, etc., and toluene is preferred.
The condensation reaction of the prepared compound 3 is carried out at the reaction temperature of 20-150 ℃, preferably 60-90 ℃.
The new compound 6 is obtained by condensation reaction of a compound 5 and 2-fluoro-6-trifluoromethyl benzyl bromide under the action of alkali:
and R is selected from H or C1-C6 alkyl. Preferably methyl, ethyl, propyl, allyl, isopropyl, isobutyl or tert-butyl; further preferred is methyl, allyl, isopropyl, isobutyl or tert-butyl.
The above condensation reaction for preparing compound 6, wherein the base may be an inorganic base or an organic base, preferably an inorganic base. The inorganic base comprises sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide, lithium hydroxide, potassium phosphate, sodium acetate, disodium hydrogen phosphate, dipotassium hydrogen phosphate and the like, and the organic base comprises triethylamine, N-diisopropylethylamine, pyridine, DBU and the like; further preferred is sodium carbonate. The reaction solvent is selected from toluene, 1, 4-dioxane, N-dimethylformamide, N-dimethylacetamide, dimethylsulfoxide, N-methylpyrrolidone, etc., and preferably N, N-dimethylformamide. The reaction temperature is between room temperature and 150 ℃, and preferably between 60 and 100 ℃.
The new compound 7 is obtained by the halogenation reaction of the compound 6 by N-halogenated succinimide:
r is selected from H and alkyl of C1-C6, and X is selected from chlorine, bromine and iodine. Wherein alkyl is preferably methyl, ethyl, propyl, allyl, isopropyl, isobutyl or tert-butyl; further preferred is methyl, allyl, isopropyl, isobutyl or tert-butyl.
In the halogenation reaction of the compound 6, the reaction solvent is selected from acetonitrile, dichloromethane, chloroform, ethyl acetate, isopropyl acetate, tetrahydrofuran, acetone, 1, 4-dioxane, toluene, etc., and preferably acetonitrile. The reaction temperature is-50 to 50 ℃, and preferably 0 to 20 ℃.
The new compound 8 is obtained by carrying out Suzuki coupling reaction on the compound 7 and 2-fluoro-3-methoxyphenylboronic acid in the presence of a catalyst:
r is selected from H and alkyl of C1-C6, and X is selected from chlorine, bromine and iodine. Wherein alkyl is preferably methyl, ethyl, propyl, allyl, isopropyl, isobutyl or tert-butyl; further preferred is methyl, allyl, isopropyl, isobutyl or tert-butyl.
The coupling reaction of the compound 7 is carried out by using a catalyst selected from tetrakis (triphenylphosphine) palladium, palladium acetate, bis (triphenylphosphine) palladium dichloride, 1' -bis (diphenylphosphino) ferrocene ] palladium dichloride, dibenzylideneacetone dipalladium, Pd-XPhos-G4 and the like, and preferably Pd-XPhos-G4. The alkali includes sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, sodium hydroxide, potassium hydroxide, lithium hydroxide, potassium phosphate, sodium acetate, disodium hydrogen phosphate, dipotassium hydrogen phosphate, etc., preferably potassium phosphate. The reaction solvent is selected from mixed solvents of water and acetonitrile, dichloromethane, trichloromethane, ethyl acetate, isopropyl acetate, tetrahydrofuran, acetone, 1, 4-dioxane, toluene and the like, and is preferably a mixed solvent of water and 1, 4-dioxane. The reaction temperature is 50-100 ℃, and preferably 70-80 ℃.
Hydrolyzing the compound 8 with acid to obtain a key intermediate compound 1:
r is selected from H and alkyl of C1-C6, and X is selected from chlorine, bromine and iodine. Wherein alkyl is preferably methyl, ethyl, propyl, allyl, isopropyl, isobutyl or tert-butyl; further preferred is methyl, allyl, isopropyl, isobutyl or tert-butyl.
The above compound 8 is hydrolyzed with an organic acid or an inorganic acid, preferably an inorganic acid. The inorganic acid is selected from hydrochloric acid, sulfuric acid, phosphoric acid, nitric acid and the like, and the organic acid is selected from formic acid, acetic acid, trifluoroacetic acid, methanesulfonic acid and the like; further preferred is hydrochloric acid. The solvent is selected from methanol, ethanol, isopropanol, acetonitrile, tetrahydrofuran, acetone, 1, 4-dioxane, etc., preferably methanol, ethanol or isopropanol. The reaction temperature is selected from 50-100 ℃, and preferably 60-90 ℃.
The invention has the beneficial effects that:
1. the preparation steps of the key intermediate compound 1 are shortened, the yield is greatly improved (from 29.68% to 51.88% in the prior art), the reaction energy consumption is low, the three wastes are less, the preparation period is short, and the industrial amplification production is easier.
2. 3-aminocrotonic acid ester which is cheap and easy to obtain can be further selected as a starting material, so that the cost of the raw material is greatly reduced, and reagents or intermediates used in each step of reaction can be purchased commercially.
3. Amino protecting group changed from Boc to cheapNot only the cost is reduced, but also the atom economy is improved and the cost is reduced.
4. The method avoids the use of high and strong irritative and explosive reagents such as borane tetrahydrofuran, butyl lithium, diketene and the like in the prior method, and also does not need to use a large amount of strong corrosive reagents such as concentrated hydrochloric acid, bromine and the like in the prior method, thereby greatly reducing the equipment requirement in the actual amplification production.
Detailed Description
The present invention is illustrated by the following examples, which should be construed as merely illustrative and not a limitation of the scope of the invention.
In the synthesis method of the key intermediate (compound 1) of oxalagril provided in this embodiment, the synthetic route is exemplified as follows:
example 1:
ethyl 3-aminocrotonate (10g, 77.42mmol) was dissolved in dry toluene (100mL), pyridine (9.18g, 116.14mmol), phenyl chloroformate (11.64mL, 92.91mmol) were added at room temperature, the suspension was raised to 75 deg.C and the reaction was stirred rapidly, LC-MS monitored the progress of the reaction, and after 4h the conversion of the starting material was complete. The reaction mixture was filtered through celite, and the filtrate was evaporated to dryness to give 19.35g of a yellow-brown oil, 90% purity, 100% yield, ms (esi): [ M + H ]]+250, directly put into the next step without purification.
Example 2:
methyl 3-aminocrotonate (10g, 86.96mmol) was dissolved in dry 1, 4-dioxane (100mL), triethylamine (18.16mL, 130.29mmol) and phenyl chloroformate (16.32g, 104.23mmol) were added at room temperature, the suspension was raised to 70 deg.C and the reaction was stirred rapidly, LC-MS monitored the progress of the reaction, and after 6h the conversion of the starting material was complete. Mixing the reaction mixtureFiltration through celite and evaporation of the filtrate to dryness gave 18.88g of a yellow-brown oil, 89% purity, 92.40% yield, ms (esi): [ M + H ]]+=236。
Example 3:
ethyl 3-aminocrotonate (10g, 77.42mmol) was dissolved in dry toluene (100mL), anhydrous potassium carbonate (16.05g, 116.14mmol), 4A molecular sieve (325 mesh, 10g) and ethyl chloroformate (10.08g, 92.91mmol) were added at room temperature, the suspension was raised to 75 deg.C, the reaction was stirred rapidly, LC-MS monitored the progress of the reaction, and the conversion of the starting material was complete after 4.5 h. The reaction mixture was filtered through celite, and the filtrate was evaporated to dryness to give 15.60g of a yellow-brown oil, 95% purity, 100% yield, ms (esi): [ M + H ]]+=202。
Example 4:
ethyl 3-aminocrotonate (10g, 77.42mmol) was dissolved in dry acetonitrile (100mL), anhydrous potassium carbonate (16.05g, 116.14mmol), 4A molecular sieve (325 mesh, 10g) and methyl chloroformate (8.78g, 92.91mmol) were added at room temperature, the suspension was raised to 75 deg.C, the reaction was stirred rapidly, LC-MS monitored the progress of the reaction, and the conversion of the starting material was complete after 4.5 h. The reaction mixture was filtered through celite and the filtrate was evaporated to dryness to give 14.67g of a yellow-brown oil, 94.69% purity, 101.22% yield, ms (esi): [ M + H ]]+=188。
Example 5:
dissolving a compound 3-1 (crude product, 19.3g, 77.43mmol) in anhydrous DMF (100mL), adding R-alpha- (formamido) phenethylamine acetate (19.19g, 85.17mmol) and anhydrous potassium carbonate (16.05g, 116.14mmol), stirring at room temperature for reaction, monitoring the reaction process by LC-MS, completely converting the raw materials after 3h, and directly heating the product without separation for the second-stage reaction.
And (3) heating the reaction liquid to 80 ℃, stirring for reaction, monitoring the reaction process by LC-MS, and completely converting the intermediate compound into the compound 5-1 after 15 hours. The mixture was cooled to room temperature, purified water (400mL) and methylene chloride (400mL) were added, and the mixture was extracted and separated. The aqueous phase was extracted once with dichloromethane (200mL), and the organic phases were combined and washed with pure water (400 mL). The organic phase was evaporated to dryness to give a brown slurry. Isopropyl ether (100mL) was added, and the mixture was slurried at room temperature for 12 hours, filtered to give an off-white cake, and vacuum-dried to give an off-white powder (13.6 g), purity of LC-MS (LC-MS) of 99.78%, yield 64.26% (based on compound 2-1), MS (ESI): [ M + H ]]+=274。1HNMR:δ2.23(3H,s),3.91-4.02(1H,d),4.05-4.13(1H,d),5.44-5.53(1H,m),5.67(1H,s),6.98-7.37(5H,m),7.93(1H,s)。
Example 6:
compound 5-1(5g, 18.3mmol) was dissolved in anhydrous DMF (50mL), anhydrous sodium carbonate (6.59g, 62.20mmol) was added, 2-fluoro-6-trifluoromethylbromobenzyl (7.05g, 27.44mmol) was added, the reaction was stirred at 80 ℃ and the progress of the reaction was monitored by LC-MS, and after 15h the starting material was completely converted. The reaction mixture was cooled to room temperature, filtered through celite, and isopropyl acetate (100mL) and pure water (100mL) were added to the filtrate, followed by extraction with stirring and liquid separation. The organic phase was washed with pure water (100mL) and separated. The organic phase was washed with saturated brine (100mL) and separated. The organic phase was evaporated to dryness to give 7.6g of yellow oil, 98.22% purity by LC-MS, 92.43% yield, MS (esi): [ M + H ]]+=450。1HNMR:δ2.25(3H,s),3.93-4.07(1H,d),4.09-4.18(1H,d),4.56(2H,s),5.46-5.55(1H,m),5.65(1H,s),6.90-7.35(7H,m),7.40-7.45(1H,m),7.99(1H,s)。
Example 7:
compound 5-1(5g, 18.3mmol) was dissolved in anhydrous DMF (50mL), anhydrous sodium carbonate (6.59g, 62.20mmol) was added, 2-fluoro-6-trifluoromethylbromobenzyl (7.05g, 27.44mmol) was added, the reaction was stirred at 50 ℃ and the progress of the reaction was monitored by LC-MS, and after 60h the starting material was substantially converted. The reaction mixture was cooled to room temperature, filtered through celite, and isopropyl acetate (100mL) and pure water (100mL) were added to the filtrate, followed by extraction with stirring and liquid separation. The organic phase was washed with pure water (100mL) and separated. The organic phase was washed with saturated brine (100mL) and separated. The organic phase was evaporated to dryness to give 5.9g of a yellow oil, purity by LC-MS 94.65%, yield 71.16%.
Example 8:
compound 5(5g, 18.3mmol) was dissolved in dry toluene (50mL), triethylamine (6.29g, 49.22mmol) was added, 2-fluoro-6-trifluoromethylbromobenzyl (7.05g, 27.44mmol) was added and the reaction stirred at 80 deg.C, LC-MS monitored the progress of the reaction, and after 40h the starting material had been essentially converted. The reaction mixture was cooled to room temperature, filtered through celite, and isopropyl acetate (100mL) and pure water (100mL) were added to the filtrate, followed by extraction with stirring and liquid separation. The organic phase was washed with pure water (100mL) and separated. The organic phase was washed with saturated brine (100mL) and separated. The organic phase was evaporated to dryness to give 6.08g of a yellow oil, 93.55% purity LC-MS and 73.95% yield.
Example 9:
compound 6-1(5g, 11.13mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-bromosuccinimide (1.98g, 11.13mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reactionIn the process, the conversion of the raw materials is complete after 12 hours. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.35g of a pale yellow foamy solid, purity of LC-MS 96.55%, yield 91.02%, MS (esi): [ M + H ]]+=528。1HNMR:δ2.13(3H,s),3.82-4.03(1H,d),4.05-4.14(1H,d),4.45(2H,s),5.33-5.63(1H,m),6.86-7.30(7H,m),7.42-7.51(1H,m),8.05(1H,s)。
Example 10:
compound 6-1(5g, 11.13mmol) was dissolved in dichloromethane (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-chlorosuccinimide (1.49g, 11.13mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase is washed with water, dried by anhydrous sodium sulfate and evaporated to dryness to obtain 4.86g of light yellow foamy solid, the purity of LC-MS is 95.33%, the yield is 90.28%, and MS (ESI): [ M + H ]]+=484。δ2.19(3H,s),3.86-4.09(1H,d),4.11-4.18(1H,d),4.49(2H,s),5.31-5.60(1H,m),6.83-7.22(7H,m),7.39-7.46(1H,m),7.98(1H,s)。
Example 11:
compound 6-1(5g, 11.13mmol) was dissolved in ethyl acetate (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-iodosuccinimide (2.5g, 11.13mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.54g of a pale yellow foamy solid, LC-MS purity 93.66%, yield 86.55%, MS (esi): [ M + H ]]+=576。δ2.28(3H,s),3.88-4.12(1H,d),4.17-4.23(1H,d),4.55(2H,s),5.36-5.67(1H,m),6.86-7.29(7H,m),7.41-7.52(1H,m),8.00(1H,s)。
Example 12:
compound 7-1-Br (5g, 9.46mmol), 2-fluoro-3-methoxyphenylboronic acid (2.09g, 12.3mmol) and potassium phosphate (6.03g, 28.39mmol) were added to a mixed solvent of 1, 4-dioxane (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, purged with nitrogen gas and oxygen purged for 10min, and a catalyst (8.14mg, 0.009mmol) was added. Heating to 70-75 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 2h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with pure water (50mL) and saturated brine (50mL), dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.21g of a pale yellow foamy solid, purity LC-MS 95.85%, yield 95.98%, MS (esi): [ M + H ]]+=574。1HNMR:δ2.23(3H,s),3.59-3.62(1H,d),3.80-3.88(1H,d),3.91(3H,s),4.51(2H,s),5.48-5.57(1H,m),6.81-7.30(10H,m),7.52-7.59(1H,m),7.97(1H,s)。
Example 13:
compound 7-1-Cl (4g, 8.27mmol), 2-fluoro-3-methoxyphenylboronic acid (1.83g, 10.75mmol), potassium phosphate (3.42g, 24.80mmol) were added to a mixed solvent of acetonitrile (48mL,12eqV) and pure water (12mL, 3eqV), the solution was stirred, purged by bubbling with nitrogen gas for deoxygenation for 10min, and catalyst (95.6mg, 0.083mmol) was added. The temperature is raised to 70 ℃ and the reaction is stirred. TLC and LC-MS monitor the reaction progress, and after 6h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 12mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (40mL) and saturated brine (40mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.23g of a pale yellow foamy solid with a purity of 92.89% by LC-MS and a yield of 89.22%.
Example 14:
compound 7-1-I (5g, 8.69mmol), 2-fluoro-3-methoxyphenylboronic acid (1.92g, 11.3mmol), sodium carbonate (2.76g, 26.07mmol) were added to a mixed solvent of toluene (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, nitrogen was bubbled through to remove oxygen for 10min, and catalyst (7.48mg, 0.009mmol) was added. The temperature is raised to 80 ℃ and the reaction is stirred. TLC and LC-MS monitor the reaction progress, and after 1h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (50mL) and saturated brine (50mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.16g of a pale yellow foamy solid with a purity of 93.73% by LC-MS and a yield of 83.46%.
Example 15:
compound 8-1(5g, 8.72mmol) was added to a mixed solvent of ethanol (25mL) and 6N hydrochloric acid (25mL), and the mixture was stirred to dissolve, heated to 80 ℃ and stirred for reaction. TLC and LC-MS monitor the reaction progress, and after 1h the conversion of the raw material is complete. Cooling to room temperature, evaporating to dryness until the volume is 5mL, adding isopropyl acetate (50mL) and pure water (50mL), and adjusting the pH of the system to be 7-8 by sodium carbonate solid under stirring. The organic phase was added with 10% phosphoric acid (50mL), extracted with stirring, and separated. Adding the water phase into isopropyl acetate (50mL), adjusting the pH of the system to 7-8 with a saturated sodium bicarbonate solution under stirring, separating, washing the organic phase with saturated saline, and evaporating to dryness to obtain a white foamy solid 4.38g, wherein the purity of LC-MS is 96.88%, and the yield is 92.1%. Ms (esi): [ M + H ] + ═ 546.
Example 16:
compound 8-1(5g, 8.72mmol) was added to a mixed solvent of isopropyl alcohol (25mL) and pure water (25mL), and stirred to dissolve, methanesulfonic acid (1.68g, 17.44mmol) was added, and the reaction was stirred at 80 ℃. TLC and LC-MS monitor the reaction progress, and after 1h the conversion of the raw material is complete. Cooling to room temperature, evaporating to dryness until the volume is 5mL, adding isopropyl acetate (50mL) and pure water (50mL), and adjusting the pH of the system to be 7-8 by sodium carbonate solid under stirring. The organic phase was added with 10% phosphoric acid (50mL), extracted with stirring, and separated. Adding the water phase into isopropyl acetate (50mL), adjusting the pH of the system to 7-8 with a saturated sodium bicarbonate solution under stirring, separating, washing the organic phase with saturated saline, and evaporating to dryness to obtain a white foamy solid 4.29g, wherein the purity of LC-MS is 96.2%, and the yield is 90.21%.
Example 17:
dissolving a compound 3-1 (crude product, 18g, 72.21mmol) in anhydrous DMAc (100mL), adding R-alpha- (acetamido) phenethylamine acetate (19.01g, 79.43mmol) and anhydrous potassium carbonate (14.97g, 108.32mmol), stirring at room temperature for reaction, monitoring the reaction process by LC-MS, completely converting the raw materials after 3h, and directly heating the product without separation for the second-stage reaction.
And (3) heating the reaction liquid to 80 ℃, stirring for reaction, monitoring the reaction process by LC-MS, and completely converting the intermediate state into the compound 5-2 after 15 hours. The mixture was cooled to room temperature, purified water (400mL) and methylene chloride (400mL) were added, and the mixture was extracted and separated. The aqueous phase was extracted once with dichloromethane (200mL), and the organic phases were combined and washed with pure water (400 mL). The organic phase was evaporated to dryness to give a brown slurry. Adding isopropyl ether (100mL), pulping at room temperature for 12h, filtering to obtain white-like filter cake, vacuum drying to obtain white-like powder 14.63g,LC-MS purity 99.33%, yield 70.53% (based on compound 2-1), MS (esi): [ M + H ]]+=288。1HNMR:δ1.80(3H,s),δ2.29(3H,s),3.60-3.66(1H,d),3.82-3.88(1H,d),5.42-5.47(1H,m),5.55(1H,s),7.18-7.31(5H,m)。
Example 18:
compound 5-2(5g, 17.4mmol) was dissolved in anhydrous DMF (50mL), anhydrous sodium carbonate (6.27g, 59.17mmol) was added, 2-fluoro-6-trifluoromethylbromobenzyl (6.71g, 26.1mmol) was added, the reaction was stirred at 80 ℃ and the progress of the reaction was monitored by LC-MS, and after 15h the starting material was completely converted. The reaction mixture was cooled to room temperature, filtered through celite, and isopropyl acetate (100mL) and pure water (100mL) were added to the filtrate, followed by extraction with stirring and liquid separation. The organic phase was washed with pure water (100mL) and separated. The organic phase was washed with saturated brine (100mL) and separated. The organic phase was evaporated to dryness to give 7.44g of yellow oil, 97.98% purity LC-MS, 92.25% yield, MS (esi): [ M + H ]]+=464。1HNMR:δ1.83(3H,s),δ2.27(3H,s),3.58-3.63(1H,d),3.79-3.85(1H,d),4.49(2H,s),5.46(1H,s),5.50-5.56(1H,m),7.20-7.33(7H,m)。7.60-7.65(1H,m)。
Example 19:
compound 6-2(5g, 10.79mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-bromosuccinimide (1.92g, 10.79mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase is washed with water, dried by anhydrous sodium sulfate and evaporated to dryness to obtain 5.28g of light yellow foamy solid, the purity of LC-MS is 96.98%, the yield is 90.24%, and MS (ESI): [ M + H ]]+=542。1HNMR:δ1.80(3H,s),δ2.23(3H,s),3.55-3.60(1H,d),3.77-3.84(1H,d),4.45(2H,s),5.46-5.53(1H,m),7.16-7.30(7H,m)。7.56-7.62(1H,m)。
Example 20:
compound 6-2(5g, 10.79mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-chlorosuccinimide (1.44g, 10.79mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.76g of a pale yellow foamy solid, LC-MS purity 93.77%, yield 88.61%, MS (esi): [ M + H ]]+=498。1HNMR:δ1.81(3H,s),δ2.22(3H,s),3.53-3.61(1H,d),3.75-3.81(1H,d),4.52(2H,s),5.49-5.54(1H,m),7.18-7.32(7H,m)。7.57-7.63(1H,m)。
Example 21:
compound 6-2(5g, 10.79mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature was reduced to 10 ℃ and N-iodosuccinimide (2.43g, 10.79mmol) was added and the reaction was stirred at 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.33g of a pale yellow foamy solid, purity of LC-MS 92.24%, yield 83.83%, MS (esi): [ M + H ]]+=590。1HNMR:δ1.83(3H,s),δ2.25(3H,s),3.52-3.63(1H,d),3.76-3.83(1H,d),4.56(2H,s),5.50-5.57(1H,m),7.19-7.34(7H,m)。7.59-7.65(1H,m)。
Example 22:
compound 7-2-Br (5g, 9.22mmol), 2-fluoro-3-methoxyphenylboronic acid (2.04g, 11.99mmol) and potassium phosphate (5.87g, 27.66mmol) were added to a mixed solvent of 1, 4-dioxane (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, purged with nitrogen gas and purged for 10min, and a catalyst (7.93mg, 0.009mmol) was added. Heating to 70-75 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 2h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with pure water (50mL) and saturated brine (50mL), dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.11g of a pale yellow foamy solid, purity of LC-MS 96.71%, yield 94.33%, MS (esi): [ M + H ]]+=588。1HNMR:δ1.87(3H,s),δ2.25(3H,s),3.56-3.64(1H,d),3.77-3.85(1H,d),3.96(3H,s),4.53(2H,s),5.49-5.59(1H,m),6.80-7.28(10H,m),7.58-7.62(1H,m)。
Example 23:
the compound 7-2-Cl (4g, 8.03mmol), 2-fluoro-3-methoxyphenylboronic acid (1.77g, 10.44mmol) and potassium phosphate (5.12g, 24.10mmol) were added to a mixed solvent of 1, 4-dioxane (48mL,12eqV) and pure water (12mL, 3eqV), the solution was stirred, nitrogen was bubbled through to remove oxygen for 10min, and the catalyst (6.91mg, 0.008mmol) was added. Heating to 75-80 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 6h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 12mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (40mL) and saturated brine (40mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.12g of a pale yellow foamy solid with a purity of 93.55% by LC-MS and a yield of 87.28%.
Example 24:
compound 7-2-I (5g, 8.48mmol), 2-fluoro-3-methoxyphenylboronic acid (1.87g, 11.03mmol) and potassium phosphate (5.40g, 25.45mmol) were added to a mixed solvent of 1, 4-dioxane (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, purged by bubbling with nitrogen gas for deoxygenation for 10min, and a catalyst (7.3mg, 0.008mmol) was added. Heating to 70-75 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 1h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (50mL) and saturated brine (50mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.09g of a pale yellow foamy solid with an LC-MS purity of 92.18% and a yield of 82.05%.
Example 25:
compound 8-2(5g, 8.51mmol) was added to a mixed solvent of ethanol (25mL) and 6N hydrochloric acid (25mL), and the mixture was stirred to dissolve and clear, and the reaction was stirred at 80 ℃. TLC and LC-MS monitor the reaction progress, and after 24h the conversion of the raw material is complete. Cooling to room temperature, evaporating to dryness until the volume is 5mL, adding isopropyl acetate (50mL) and pure water (50mL), and adjusting the pH of the system to be 7-8 by sodium carbonate solid under stirring. The organic phase was added with 10% phosphoric acid (50mL), extracted with stirring, and separated. Adding the water phase into isopropyl acetate (50mL), adjusting the pH value of the system to 7-8 by using a saturated sodium bicarbonate solution under stirring, separating, washing an organic phase by using saturated saline solution, and evaporating to dryness to obtain 4.09g of a white foamy solid, wherein the purity of LC-MS is 95.13%, and the yield is 88.1%. Ms (esi): [ M + H ] + ═ 546.
Example 26:
dissolving a compound 3-1 (crude product, 18g, 72.21mmol) in anhydrous DMF (100mL), adding R-alpha- (isobutyramido) phenethylamine acetate (21.16g, 79.43mmol) and anhydrous potassium carbonate (14.97g, 108.32mmol), stirring at room temperature for reaction, monitoring the reaction process by LC-MS, completely converting the raw material after 3h, and directly heating the product without separation for the second-stage reaction.
And (3) heating the reaction solution to 80 ℃, stirring for reaction, monitoring the reaction process by LC-MS, and completely converting the intermediate state into a compound 5-3 after 15 hours. The mixture was cooled to room temperature, purified water (400mL) and methylene chloride (400mL) were added, and the mixture was extracted and separated. The aqueous phase was extracted once with dichloromethane (200mL), and the organic phases were combined and washed with pure water (400 mL). The organic phase was evaporated to dryness to give a brown slurry. Isopropyl ether (100mL) was added, and the mixture was slurried at room temperature for 12 hours, filtered to give an off-white cake, and vacuum-dried to give an off-white powder (15.81 g), purity of LC-MS (99.57%) and yield (69.42%) based on Compound 2-1, MS (ESI): [ M + H ]]+=316。1HNMR:δ1.21-1.23(6H,s),2.23(3H,s),2.70(1H,m),3.61-3.67(1H,d),3.89-3.86(1H,d),5.46(1H,s),5.49-5.54(1H,m),7.15-7.48(5H,m)。
Example 27:
dissolve compound 5-3(5g, 15.85mmol) in anhydrous DMF (50mL), add anhydrous sodium carbonate (5.71g, 53.90mmol), add 2-fluoro-6-trifluoromethyl benzyl bromide (6.11g, 23.78mmol), raise to 80 deg.C and stir the reaction, LC-MS monitors the progress of the reaction, after 15h the starting material is completely converted. The reaction mixture was cooled to room temperature, filtered through celite, and isopropyl acetate (100mL) and pure water (100mL) were added to the filtrate, followed by extraction with stirring and liquid separation. The organic phase was washed with pure water (100mL) and separated. The organic phase was washed with saturated brine (100mL) and separated. The organic phase was evaporated to dryness to give 7.12g of yellow oil, 98.1% purity by LC-MS, 91.37% yield, MS (esi): [ M + H ]]+=492。1HNMR:δ1.22-1.26(6H,s),2.25(3H,s),2.71(1H,m),3.64-3.70(1H,d),3.92-3.95(1H,d),4.50(2H,s),5.48(1H,s),5.52-5.60(1H,m),7.12-7.46(7H,m),7.59-7.63(1H,m)。
Example 28:
compound 6-3(5g, 10.17mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-bromosuccinimide (1.81g, 10.17mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.33g of a pale yellow foamy solid, purity of LC-MS 96.75%, yield 91.85%, MS (esi): [ M + H ]]+=570。1HNMR:δ1.19-1.23(6H,s),2.21(3H,s),2.69(1H,m),3.61-3.68(1H,d),3.88-3.93(1H,d),4.52(2H,s),5.50-5.59(1H,m),7.13-7.44(7H,m),7.57-7.61(1H,m)。
Example 29:
compound 6-3(5g, 10.17mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-chlorosuccinimide (1.36g, 10.17mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase is washed with water, dried by anhydrous sodium sulfate and evaporated to dryness to obtain 4.86g of light yellow foamy solid, the purity of LC-MS is 92.99%, the yield is 90.83%, and MS (ESI): [ M + H ]]+=526。1HNMR:δ1.20-1.26(6H,s),2.24(3H,s),2.71(1H,m),3.63-3.69(1H,d),3.86-3.92(1H,d),4.50(2H,s),5.53-5.62(1H,m),7.11-7.47(7H,m),7.55-7.65(1H,m)。
Example 30:
compound 6-3(5g, 10.17mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-iodosuccinimide (2.29g, 10.17mmol) is added, and the reaction is stirred at 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.50g of a pale yellow foamy solid, LC-MS purity 93.03%, yield 87.57%, MS (esi): [ M + H ]]+=618。1HNMR:δ1.22-1.29(6H,s),2.27(3H,s),2.72(1H,m),3.62-3.71(1H,d),3.87-3.95(1H,d),4.53(2H,s),5.54-5.66(1H,m),7.15-7.55(7H,m),7.60-7.68(1H,m)。
Example 31:
compound 7-3-Br (5g, 8.77mmol), 2-fluoro-3-methoxyphenylboronic acid (1.94g, 11.40mmol) and potassium phosphate (5.58g, 26.30mmol) were added to a mixed solvent of 1, 4-dioxane (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, purged by bubbling with nitrogen gas for 10min, and a catalyst (7.54mg, 0.009mmol) was added. Heating to 70-75 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 2h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with pure water (50mL) and saturated brine (50mL), dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.07g of a pale yellow foamy solid, purity of LC-MS 95.89%, yield 93.95%, MS (esi): [ M + H ]]+=616。1HNMR:δ1.18-1.26(6H,s),2.25(3H,s),2.69(1H,m),3.50-3.62(1H,d),3.76-3.83(1H,d),3.94(3H,s),4.55(2H,s),5.51-5.63(1H,m),6.81-7.29(10H,m),7.56-7.61(1H,m)。
Example 32:
the compound 7-3-Cl (4g, 7.61mmol), 2-fluoro-3-methoxyphenylboronic acid (1.68g, 9.89mmol) and potassium phosphate (4.84g, 22.82mmol) were added to a mixed solvent of 1, 4-dioxane (48mL,12eqV) and pure water (12mL, 3eqV), the solution was stirred, nitrogen was bubbled through to remove oxygen for 10min, and the catalyst (6.54mg, 0.008mmol) was added. Heating to 75-80 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 6h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 12mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (40mL) and saturated brine (40mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.14g of a pale yellow foamy solid with a purity of 92.96% by LC-MS and a yield of 88.42%.
Example 33:
compound 7-3-I (5g, 8.10mmol), 2-fluoro-3-methoxyphenylboronic acid (1.79g, 10.53mmol) and potassium phosphate (5.16g, 24.30mmol) were added to a mixed solvent of 1, 4-dioxane (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, nitrogen was bubbled through to remove oxygen for 10min, and a catalyst (6.97mg, 0.008mmol) was added. Heating to 70-75 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 1h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (50mL) and saturated brine (50mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.22g of a pale yellow foamy solid with a purity of 93.01% by LC-MS and a yield of 84.64%.
Example 34:
the compound 8-3(5g, 8.12mmol) was added to a mixed solvent of ethanol (25mL) and 6N hydrochloric acid (25mL), and the mixture was stirred to dissolve and clear, and heated to 80 ℃ to stir the reaction. TLC and LC-MS monitor the reaction progress, and after 24h the conversion of the raw material is complete. Cooling to room temperature, evaporating to dryness until the volume is 5mL, adding isopropyl acetate (50mL) and pure water (50mL), and adjusting the pH of the system to be 7-8 by sodium carbonate solid under stirring. The organic phase was added with 10% phosphoric acid (50mL), extracted with stirring, and separated. Adding the water phase into isopropyl acetate (50mL), adjusting the pH value of the system to 7-8 with a saturated sodium bicarbonate solution under stirring, separating, washing the organic phase with saturated saline solution, and evaporating to dryness to obtain 4.01g of white foamy solid, wherein the purity of LC-MS is 94.69%, and the yield is 90.50%. Ms (esi): [ M + H ] + ═ 546.
Example 35:
dissolving a compound 3-1 (crude product, 18g, 72.21mmol) in anhydrous DMSO (100mL), adding R-alpha- (isovaleryl amino) phenethylamine acetate (22.35g, 79.43mmol) and anhydrous potassium carbonate (14.97g, 108.32mmol), stirring at room temperature for reaction, monitoring the reaction process by LC-MS, completely converting the raw materials after 3h, and directly heating the product without separation for the second-stage reaction.
And (3) heating the reaction liquid to 80 ℃, stirring for reaction, monitoring the reaction process by LC-MS, and completely converting the intermediate state into a compound 5-4 after 15 hours. The mixture was cooled to room temperature, purified water (400mL) and methylene chloride (400mL) were added, and the mixture was extracted and separated. The aqueous phase was extracted once with dichloromethane (200mL), and the organic phases were combined and washed with pure water (400 mL). The organic phase was evaporated to dryness to give a brown slurry. Isopropyl ether (100mL) was added, and the mixture was slurried at room temperature for 12 hours, filtered to give an off-white cake, and vacuum-dried to give an off-white powder (16.33 g), purity of LC-MS (LC-MS) of 99.30%, yield 68.66% (based on compound 2-1), MS (ESI): [ M + H ]]+=330。1HNMR:δ0.95-0.98(6H,d),2.06-2.11(1H,m),2.15-2.20(2H,d),2.32(3H,s),3.65-3.71(1H,d),3.89-3.98(1H,d),5.47-5.52(1H,m),5.68(1H,s),7.17-7.43(5H,m)。
Example 36:
dissolve compound 5-4(5g, 15.18mmol) in anhydrous DMF (50mL), add anhydrous sodium carbonate (5.47g, 51.61mmol), add 2-fluoro-6-trifluoromethyl benzyl bromide (5.85g, 22.77mmol), raise to 80 deg.C and stir the reaction, LC-MS monitors the progress of the reaction, after 15h the starting material is completely converted. The reaction mixture was cooled to room temperature, filtered through celite, and isopropyl acetate (100mL) and pure water (100mL) were added to the filtrate, followed by extraction with stirring and liquid separation. The organic phase was washed with pure water (100mL) and separated. The organic phase was washed with saturated brine (100mL) and separated. The organic phase was evaporated to dryness to give 7.05g of yellow oil, 97.76% purity LC-MS, 91.88% yield, MS (esi): [ M + H ]]+=506。1HNMR:δ1.01-1.06(6H,d),2.09-2.13(1H,m),2.18-2.22(2H,d),2.33(3H,s),3.62-3.68(1H,d),3.85-4.00(1H,d),4.56(2H,s),5.44-5.50(1H,m),5.66(1H,s),7.20-7.49(7H,m),7.66-7.70(1H,m)。
Example 37:
compound 6-4(5g, 9.89mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-bromosuccinimide (1.76g, 9.89mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.23g of a pale yellow foamy solid, purity of LC-MS 95.81%, yield 90.48%, MS (esi): [ M + H ]]+=585。1HNMR:δ0.99-1.04(6H,d),2.11-2.15(1H,m),2.17-2.21(2H,d),2.30(3H,s),3.65-3.72(1H,d),3.83-4.02(1H,d),4.58(2H,s),5.41-5.48(1H,m),7.18-7.47(7H,m),7.65-7.69(1H,m)。
Example 38:
compound 6-4(5g, 10.17mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-chlorosuccinimide (1.32g, 10.17mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give a pale yellow foamy solid (4.80 g), LC-MS purity 93.23%, yield 89.88%, MS (esi): [ M + H ]]+=540。1HNMR:δ1.00-1.06(6H,d),2.12-2.16(1H,m),2.18-2.23(2H,d),2.34(3H,s),3.64-3.70(1H,d),3.81-3.98(1H,d),4.55(2H,s),5.39-5.45(1H,m),7.16-7.44(7H,m),7.63-7.66(1H,m)。
Example 39:
compound 6-4(5g, 9.89mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-iodosuccinimide (2.23g, 9.89mmol) is added, and the reaction is stirred at 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give a pale yellow foamy solid 5.31g, LC-MS purity 91.89%, yield 85.02%, MS (esi): [ M + H ]]+=632。1HNMR:δ1.02-1.09(6H,d),2.14-2.19(1H,m),2.18-2.25(2H,d),2.37(3H,s),3.65-3.74(1H,d),3.85-4.05(1H,d),4.60(2H,s),5.40-5.47(1H,m),7.18-7.49(7H,m),7.69-7.71(1H,m)。
Example 40:
compound 7-4-Br (5g, 8.56mmol), 2-fluoro-3-methoxyphenylboronic acid (1.89g, 11.12mmol) and potassium phosphate (5.45g, 25.67mmol) were added to a mixed solvent of 1, 4-dioxane (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, purged with nitrogen gas and oxygen purged for 10min, and a catalyst (7.36mg, 0.009mmol) was added. Heating to 70-75 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 2h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with pure water (50mL) and saturated brine (50mL), dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.00g of a pale yellow foamy solid, purity of LC-MS 95.11%, yield 92.82%, MS (esi): [ M + H ]]+=630。1HNMR:δ0.96-1.02(6H,d),2.13-2.16(1H,m),2.16-2.24(2H,d),2.35(3H,s),3.63-3.71(1H,d),3.81(3H,s),3.89-4.07(1H,d),4.62(2H,s),5.39-5.45(1H,m),7.22-7.53(10H,m),7.70-7.72(1H,m)。
Example 41:
the compound 7-4-Cl (4g, 7.41mmol), 2-fluoro-3-methoxyphenylboronic acid (1.64g, 9.63mmol) and potassium phosphate (4.72g, 22.22mmol) were added to a mixed solvent of 1, 4-dioxane (48mL,12eqV) and pure water (12mL, 3eqV), the solution was stirred, nitrogen was bubbled through to remove oxygen for 10min, and the catalyst (6.37mg, 0.007mmol) was added. Heating to 75-80 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 6h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 12mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (40mL) and saturated brine (40mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.09g of a pale yellow foamy solid with a purity of LC-MS of 92.10% and a yield of 87.69%.
Example 42:
compound 7-4-I (5g, 7.92mmol), 2-fluoro-3-methoxyphenylboronic acid (1.75g, 10.29mmol) and potassium phosphate (5.04g, 23.76mmol) were added to a mixed solvent of 1, 4-dioxane (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, purged by bubbling with nitrogen gas for deoxygenation for 10min, and a catalyst (6.81mg, 0.008mmol) was added. Heating to 70-75 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 1h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (50mL) and saturated brine (50mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.19g of a pale yellow foamy solid with a purity of 92.16% by LC-MS and a yield of 84.04%.
Example 43:
the compound 8-4(5g, 7.94mmol) was added to a mixed solvent of ethanol (25mL) and 6N hydrochloric acid (25mL), and the mixture was stirred to dissolve and clear, heated to 80 ℃ and stirred for reaction. TLC and LC-MS monitor the reaction progress, and after 24h the conversion of the raw material is complete. Cooling to room temperature, evaporating to dryness until the volume is 5mL, adding isopropyl acetate (50mL) and pure water (50mL), and adjusting the pH of the system to be 7-8 by sodium carbonate solid under stirring. The organic phase was added with 10% phosphoric acid (50mL), extracted with stirring, and separated. Adding the water phase into isopropyl acetate (50mL), adjusting the pH of the system to 7-8 with a saturated sodium bicarbonate solution under stirring, separating, washing the organic phase with saturated saline, and evaporating to dryness to obtain a white foamy solid 3.87g, wherein the purity of LC-MS is 95.25%, and the yield is 89.34%. Ms (esi): [ M + H ] + ═ 546.
Example 44:
dissolving the compound 3-1 (crude product, 18g, 72.21mmol) in anhydrous DMF (100mL), adding R-alpha- (tert-amyl amido) phenethylamine acetate (22.35g, 79.43mmol) and anhydrous potassium carbonate (14.97g, 108.32mmol), stirring at room temperature for reaction, monitoring the reaction progress by LC-MS, completely converting the raw material after 3h, and directly heating the product without separation for the second-stage reaction.
And (3) heating the reaction liquid to 80 ℃, stirring for reaction, monitoring the reaction process by LC-MS, and completely converting the intermediate state into a compound 5-5 after 15 hours. The mixture was cooled to room temperature, purified water (400mL) and methylene chloride (400mL) were added, and the mixture was extracted and separated. The aqueous phase was extracted once with dichloromethane (200mL), and the organic phases were combined and washed with pure water (400 mL). The organic phase was evaporated to dryness to give a brown slurry. Isopropyl ether (100mL) was added, and the mixture was slurried at room temperature for 12 hours, filtered to give an off-white cake, and vacuum-dried to give an off-white powder (16.77 g), purity of LC-MS (LC-MS) of 99.60%, yield 70.51% (based on compound 2-1), MS (ESI): [ M + H ]]+=330。1HNMR:δ1.25(9H,s),2.30(3H,s),3.51-3.60(1H,d),3.87-3.93(1H,d),5.50-5.62(1H,m),5.80(1H,s),7.14-7.43(5H,m)。
Example 45:
dissolve compound 5-5(5g, 15.18mmol) in anhydrous DMF (50mL), add anhydrous sodium carbonate (5.47g, 51.61mmol), add 2-fluoro-6-trifluoromethyl benzyl bromide (5.85g, 22.77mmol), raise to 80 deg.C and stir the reaction, LC-MS monitors the progress of the reaction, after 15h the starting material is completely converted. The reaction mixture was cooled to room temperature, filtered through celite, and isopropyl acetate (100mL) and pure water (100mL) were added to the filtrate, followed by extraction with stirring and liquid separation. The organic phase was washed with pure water (100mL) and separated. The organic phase was washed with saturated brine (100mL) and separated. The organic phase was evaporated to dryness to give 7.06g of yellow oil, 97.79% purity LC-MS, 92.01% yield, MS (esi): [ M + H ]]+=506。1HNMR:δ1.22(9H,s),2.28(3H,s),3.50-3.58(1H,d),3.86-3.95(1H,d),4.50(2H,s),5.49-5.60(1H,m),5.82(1H,s),7.15-7.51(7H,m),7.66-7.70(1H,m)。
Example 46:
compound 6-5(5g, 9.89mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-bromosuccinimide (1.76g, 9.89mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.04g of a pale yellow foamy solid, purity of LC-MS 95.51%, yield 87.19%, MS (esi): [ M + H ]]+=584。1HNMR:δ1.24(9H,s),2.31(3H,s),3.49-3.56(1H,d),3.85-3.94(1H,d),4.52(2H,s),5.51-5.59(1H,m),7.13-7.48(7H,m),7.62-7.66(1H,m)。
Example 47:
compound 6-5(5g, 9.89mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-chlorosuccinimide (1.32g, 9.89mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give a pale yellow foamy solid (4.76 g), LC-MS purity 91.83%, yield 89.13%, MS (esi): [ M + H ]]+=540。1HNMR:δ1.22(9H,s),2.32(3H,s),3.47-3.54(1H,d),3.83-3.91(1H,d),4.49(2H,s),5.50-5.59(1H,m),7.11-7.46(7H,m),7.60-7.63(1H,m)。
Example 48:
compound 6-5(5g, 9.89mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-iodosuccinimide (2.23g, 9.89mmol) is added, and the reaction is stirred at 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.46g of a pale yellow foamy solid, purity of LC-MS 91.98%, yield 87.43%, MS (esi): [ M + H ]]+=632。1HNMR:δ1.21(9H,s),2.33(3H,s),3.45-3.54(1H,d),3.81(3H,s),3.86-3.97(1H,d),4.58(2H,s),5.50-5.59(1H,m),7.01-7.53(10H,m),7.61-7.67(1H,m)。
Example 49:
compound 7-5-Br (5g, 8.56mmol), 2-fluoro-3-methoxyphenylboronic acid (1.89g, 11.12mmol) and potassium phosphate (5.45g, 25.67mmol) were added to a mixed solvent of 1, 4-dioxane (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, purged with nitrogen gas and oxygen purged for 10min, and a catalyst (7.36mg, 0.009mmol) was added. Heating to 70-75 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 2h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with pure water (50mL) and saturated brine (50mL), dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.97g of a pale yellow foamy solid, with a purity of LC-MS of 96.06%, yield of 92.26%, MS (esi): [ M + H ]]+=630。1HNMR:δ1.26(9H,s),2.34(3H,s),3.49-3.56(1H,d),3.84-3.93(1H,d),4.55(2H,s),5.52-5.61(1H,m),7.13-7.50(7H,m),7.63-7.71(1H,m)。
Example 50:
the compound 7-5-Cl (4g, 7.41mmol), 2-fluoro-3-methoxyphenylboronic acid (1.64g, 9.63mmol) and potassium phosphate (4.72g, 22.22mmol) were added to a mixed solvent of 1, 4-dioxane (48mL,12eqV) and pure water (12mL, 3eqV), the solution was stirred, nitrogen was bubbled through to remove oxygen for 10min, and the catalyst (6.37mg, 0.007mmol) was added. Heating to 75-80 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 6h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 12mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (40mL) and saturated brine (40mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.10g of a pale yellow foamy solid with a purity of 93.31% by LC-MS and a yield of 87.90%.
Example 51:
compound 7-5-I (5g, 7.92mmol), 2-fluoro-3-methoxyphenylboronic acid (1.75g, 10.29mmol) and potassium phosphate (5.04g, 23.76mmol) were added to a mixed solvent of 1, 4-dioxane (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, purged by bubbling with nitrogen gas for deoxygenation for 10min, and a catalyst (6.81mg, 0.008mmol) was added. Heating to 70-75 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 1h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (50mL) and saturated brine (50mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.18g of a pale yellow foamy solid with a purity of LC-MS of 93.55% and a yield of 83.84%.
Example 52:
the compound 8-5(5g, 7.94mmol) was added to a mixed solvent of ethanol (25mL) and 6N hydrochloric acid (25mL), and the mixture was stirred to dissolve and clear, heated to 80 ℃ and stirred for reaction. TLC and LC-MS monitor the reaction progress, and after 24h the conversion of the raw material is complete. Cooling to room temperature, evaporating to dryness until the volume is 5mL, adding isopropyl acetate (50mL) and pure water (50mL), and adjusting the pH of the system to be 7-8 by sodium carbonate solid under stirring. The organic phase was added with 10% phosphoric acid (50mL), extracted with stirring, and separated. Adding the water phase into isopropyl acetate (50mL), adjusting the pH value of the system to 7-8 by using a saturated sodium bicarbonate solution under stirring, separating liquid, washing an organic phase by using saturated saline solution, and evaporating to dryness to obtain a white foamy solid 3.85g, wherein the purity of LC-MS is 95.09%, and the yield is 88.87%. Ms (esi): [ M + H ] + ═ 546.
Example 53:
dissolving the compound 3-1 (crude product, 18g, 72.21mmol) in anhydrous DMF (100mL), adding R-alpha- (acrylamido) phenethylamine acetate (19.96g, 79.43mmol) and anhydrous potassium carbonate (14.97g, 108.32mmol), stirring at room temperature for reaction, monitoring the reaction progress by LC-MS, completely converting the raw material after 3h, and directly heating the product without separation for the second-stage reaction.
And (3) heating the reaction liquid to 80 ℃, stirring for reaction, monitoring the reaction process by LC-MS, and completely converting the intermediate state into a compound 5-6 after 15 hours. The mixture was cooled to room temperature, purified water (400mL) and methylene chloride (400mL) were added, and the mixture was extracted and separated. The aqueous phase was extracted once with dichloromethane (200mL), and the organic phases were combined and washed with pure water (400 mL). The organic phase was evaporated to dryness to give a brown slurry. Isopropyl ether (100mL) was added, and the mixture was slurried at room temperature for 12 hours, filtered to give an off-white cake, and vacuum-dried to give 15.31g of an off-white powder, purity 99.38% by LC-MS, yield 70.84% (based on Compound 2-1), MS (ESI): [ M + H ]]+=300。1HNMR:δ2.28(3H,s),3.58-3.62(1H,d),3.86-3.93(1H,d),5.49-5.52(1H,m),5.56(1H,s),5.71-5.73(1H,m),6.01-6.04(1H,m),6.33-6.36(1H,m),7.22-7.35(5H,m)。
Example 54:
dissolve 5-6(5g, 16.70mmol) in anhydrous DMF (50mL), add anhydrous sodium carbonate (6.02g, 56.79mmol), add 2-fluoro-6-trifluoromethyl benzyl bromide (6.44g, 25.06mmol), raise to 80 deg.C and stir the reaction, LC-MS monitors the progress of the reaction, and after 15h complete conversion of the starting material. The reaction mixture was cooled to room temperature, filtered through celite, and isopropyl acetate (100mL) and pure water (100mL) were added to the filtrate, followed by extraction with stirring and liquid separation. The organic phase was washed with pure water (100mL) and separated. The organic phase was washed with saturated brine (100mL) and separated. The organic phase was evaporated to dryness to give 7.22g of a yellow oil, LC-MS purity 97.56%, yield 90.91%, MS (esi): [ M + H ]]+=476。1HNMR:δ2.26(3H,s),3.55-3.61(1H,d),3.83-3.89(1H,d),4.49(2H,s),5.46-5.50(1H,m),5.55(1H,s),5.68-5.70(1H,m),5.99-6.01(1H,m),6.30-6.32(1H,m),7.20-7.42(7H,m),7.59-7.65(1H,m)。
Example 55:
compound 6-6(5g, 10.52mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-bromosuccinimide (1.87g, 10.17mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.18g of a pale yellow foamy solid, purity of LC-MS 95.55%, yield 88.86%, MS (esi): [ M + H ]]+=554。1HNMR:δ2.24(3H,s),3.52-3.60(1H,d),3.81-3.88(1H,d),4.50(2H,s),5.44-5.48(1H,m),5.66-5.68(1H,m),5.97-6.00(1H,m),6.28-6.31(1H,m),7.19-7.44(7H,m),7.55-7.62(1H,m)。
Example 56:
compound 6-6(5g, 10.52mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature is reduced to 10 ℃, N-chlorosuccinimide (1.40g, 10.52mmol) is added, and the reaction is stirred at the temperature of 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.78g of a pale yellow foamy solid, purity of LC-MS 92.32%, yield 89.14%, MS (esi): [ M + H ]]+=510。1HNMR:δ2.27(3H,s),3.50-3.58(1H,d),3.80-3.86(1H,d),4.48(2H,s),5.42-5.47(1H,m),5.63-5.67(1H,m),5.97-6.01(1H,m),6.26-6.30(1H,m),7.16-7.42(7H,m),7.54-7.62(1H,m)。
Example 57:
compound 6-6(5g, 10.52mmol) was dissolved in acetonitrile (50mL) and the solution was stirred. The temperature was reduced to 10 ℃ and N-iodosuccinimide (2.37g, 10.52mmol) was added and the reaction was stirred at 10-15 ℃. TLC and LC-MS monitor the reaction progress, and after 12h the conversion of the starting material is complete. A saturated sodium bicarbonate solution (50mL) was added thereto, and the mixture was stirred for 10min and then separated. The organic phase was washed with water, dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.46g of a pale yellow foamy solid, purity of LC-MS 91.98%, yield 86.34%, MS (esi): [ M + H ]]+=602。1HNMR:δ2.25(3H,s),3.54-3.61(1H,d),3.85-3.89(1H,d),4.52(2H,s),5.46-5.51(1H,m),5.66-5.71(1H,m),6.00-6.04(1H,m),6.31-6.34(1H,m),7.23-7.47(7H,m),7.61-7.68(1H,m)。
Example 58:
compound 7-6-Br (5g, 9.02mmol), 2-fluoro-3-methoxyphenylboronic acid (1.99g, 11.73mmol) and potassium phosphate (5.74g, 27.06mmol) were added to a mixed solvent of 1, 4-dioxane (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, purged with nitrogen gas and purged for 10min, and a catalyst (7.76mg, 0.009mmol) was added. Heating to 70-75 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 2h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with pure water (50mL) and saturated brine (50mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 5.02g of a pale yellow foamy solid, LC-MS purity 93.90%, yield 92.83%, MS (esi): [ M + H ]]+=600。1HNMR:δ2.22(3H,s),3.51-3.58(1H,d),3.81(3H,s),3.86-3.91(1H,d),4.51(2H,s),5.44-5.50(1H,m),5.64-5.68(1H,m),6.01-6.04(1H,m),6.30-6.33(1H,m),7.00-7.47(10H,m),7.57-7.66(1H,m)。
Example 59:
the compound 7-6-Cl (4g, 7.84mmol), 2-fluoro-3-methoxyphenylboronic acid (1.73g, 10.20mmol) and potassium phosphate (5.0g, 23.53mmol) were added to a mixed solvent of 1, 4-dioxane (48mL,12eqV) and pure water (12mL, 3eqV), the solution was stirred, nitrogen was bubbled through to remove oxygen for 10min, and the catalyst (6.75mg, 0.008mmol) was added. Heating to 75-80 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 6h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 12mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (40mL) and saturated brine (40mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.22g of a pale yellow foamy solid with a purity of 92.50% by LC-MS and a yield of 89.72%.
Example 60:
compound 7-6-I (5g, 8.31mmol), 2-fluoro-3-methoxyphenylboronic acid (1.84g, 10.81mmol) and potassium phosphate (5.29g, 24.94mmol) were added to a mixed solvent of 1, 4-dioxane (60mL,12eqV) and pure water (15mL, 3eqV), the solution was stirred, purged by bubbling with nitrogen gas for deoxygenation for 10min, and a catalyst (7.15mg, 0.008mmol) was added. Heating to 70-75 deg.c and stirring for reaction. TLC and LC-MS monitor the reaction progress, and after 1h the conversion of the raw material is complete. The temperature was lowered to room temperature, the insoluble matter was removed by Celite filtration, the filtrate was evaporated to 15mL, isopropyl acetate (50mL) and pure water (50mL) were added, and the extract was stirred and separated. The organic phase was washed with purified water (50mL) and saturated brine (50mL) in this order, dried over anhydrous sodium sulfate, and evaporated to dryness to give 4.35g of a pale yellow foamy solid with a purity of 92.79% by LC-MS and a yield of 87.26%.
Example 61:
the compound 8-6(5g, 8.34mmol) was added to a mixed solvent of ethanol (25mL) and 6N hydrochloric acid (25mL), and the mixture was stirred to dissolve and clear, and the reaction was stirred at 80 ℃. TLC and LC-MS monitor the reaction progress, and after 24h the conversion of the raw material is complete. Cooling to room temperature, evaporating to dryness until the volume is 5mL, adding isopropyl acetate (50mL) and pure water (50mL), and adjusting the pH of the system to be 7-8 by sodium carbonate solid under stirring. The organic phase was added with 10% phosphoric acid (50mL), extracted with stirring, and separated. Adding the water phase into isopropyl acetate (50mL), adjusting the pH value of the system to 7-8 by using a saturated sodium bicarbonate solution under stirring, separating, washing an organic phase by using saturated saline solution, and evaporating to dryness to obtain 4.10g of a white foamy solid, wherein the purity of LC-MS is 95.04%, and the yield is 90.12%. Ms (esi): [ M + H ] + ═ 546.
Use of compound 1:
example 62:
under nitrogen protection, dissolving compound 1(5g, 9.17mmol) in anhydrous DMF (10mL), adding ethyl bromobutyrate (2.32g, 11.92mmol) and DIPEA (1.78g, 13.75mmol) in sequence, and adding sodium iodide (0.14g, 0.9 mmol); after the addition, the temperature is raised to 52 ℃, and the reaction is stirred for 20 hours. Cooling to room temperature, adding isopropyl acetate (50mL) and water (50mL), stirring, extracting, separating, washing organic phase (50mL, 10eqV) once, adding 10% phosphoric acid (75g), stirring, extracting, separating, and collecting water layer; the organic phase was extracted once with 10% phosphoric acid (10g), the aqueous layers were combined and washed once with isopropyl acetate (20 mL); separating, adding isopropyl acetate (50mL) into the acid water phase, adjusting the pH to 8-9 with potassium carbonate solid, stirring, extracting, separating, washing the organic phase with saturated saline solution, drying for 2h with anhydrous sodium sulfate, filtering, evaporating the filtrate to dryness to obtain colorless oil 4.63g, with the purity of 95.31% and the yield of 76.58%. Ms (esi): [ M + H ] + -660.
Example 63:
to a solution of compound 9(4.6g, 6.97mmol) in ethanol (23mL) was added a solution consisting of sodium hydroxide (0.58g, 14.64mmol) and water (17.6 mL); after the addition, the reaction was stirred at 25 ℃ for 4 hours. The reaction mixture was concentrated, and the residue was added to pure water (13.8mL) and evaporated to 23 mL; EA (13.8mL) and pure water (23mL) were added, the mixture was extracted with stirring, the mixture was separated, the aqueous phase was washed once more with EA (13.8mL), methyl isobutyl ketone (13.8mL) was added, and the mixture was concentrated to 46 mL; adding sodium chloride (6g, 1.3eqM) and methyl isobutyl ketone (32mL) at 25-30 ℃, stirring for 10min, separating liquid, concentrating an organic phase to 11.5mL, and filtering through diatomite; and (3) slowly dropping the filtrate into well-stirred n-heptane (46mL) at the temperature of 10 ℃, stirring for 2 hours after dropping, filtering, and drying a filter cake to obtain 3.89g of oxa-rogue sodium with the purity of 99.37 percent and the yield of 85.35 percent. Ms (esi): [ M + H ] + ═ 632(elagolix form).
Claims (13)
5. The preparation method of the compound 5 comprises the following steps of carrying out condensation reaction on a compound 3 with a formula shown in the specification and R-alpha- (acylamino) phenethylamine to obtain an intermediate compound 4, and carrying out cyclization reaction to obtain a new compound 5:
said R1Selected from C1-C12 substituted or unsubstituted alkyl, alkenyl, alkynyl, aryl; and R is selected from H or C1-C6 alkyl.
6. A process for the preparation of compound 5 according to claim 5, characterized in that: after the condensation reaction of the compound 3 is finished, directly heating by a one-pot method to carry out cyclization reaction to obtain a compound 5.
7. A process for the preparation of compound 5 according to claim 5, characterized in that: compound 3 is obtained by condensation reaction of compound 2 of the formula with chloroformate:
said R1Selected from the group consisting of C1-C12 substituted or unsubstituted alkyl, alkenyl, alkynyl and aryl groups, said R2Is selected from C1-C12 substituted or unsubstituted alkyl, alkenyl, alkynyl and aryl.
9. A process for the preparation of compound 1 according to claim 8, characterized in that: the compound 8 is obtained by carrying out Suzuki coupling reaction on a compound 7 with the following formula and 2-fluoro-3-methoxyphenylboronic acid in the presence of a catalyst:
r is selected from H and C1-C6 alkyl, and X is chlorine, bromine or iodine.
11. A process for the preparation of compound 1 according to claim 10, characterized in that: the compound 6 is obtained by condensation reaction of a compound 5 with a formula shown in the specification and 2-fluoro-6-trifluoromethyl benzyl bromide under the action of alkali:
and R is selected from H or C1-C6 alkyl.
12. A process for the preparation of compound 1 according to claim 11, characterized in that: the compound 5 is obtained by the preparation method of any one of claims 5 to 7.
13. The compounds 2-8 are used for preparing oxalagogrel and intermediates thereof.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010421962.XA CN113683572A (en) | 2020-05-18 | 2020-05-18 | Intermediate of oxadegril and preparation method and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010421962.XA CN113683572A (en) | 2020-05-18 | 2020-05-18 | Intermediate of oxadegril and preparation method and application thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN113683572A true CN113683572A (en) | 2021-11-23 |
Family
ID=78575711
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010421962.XA Pending CN113683572A (en) | 2020-05-18 | 2020-05-18 | Intermediate of oxadegril and preparation method and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113683572A (en) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1819829A (en) * | 2003-07-07 | 2006-08-16 | 纽罗克里生物科学有限公司 | Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| US20110098472A1 (en) * | 2007-11-07 | 2011-04-28 | Neurocrine Biosciences, Inc. | Processes for the preparation of uracil derivatives |
| CN108586359A (en) * | 2018-06-26 | 2018-09-28 | 杭州科巢生物科技有限公司 | A kind of synthetic method for disliking La Geli |
| CN110669014A (en) * | 2019-11-14 | 2020-01-10 | 重庆医药高等专科学校 | Preparation method of oxalagogri intermediate |
| US20200024239A1 (en) * | 2018-07-23 | 2020-01-23 | Abbvie Inc. | Elagolix Sodium Compositions and Processes |
| CN110759870A (en) * | 2019-12-06 | 2020-02-07 | 上海博璞诺科技发展有限公司 | Synthesis method of oxalagogri intermediate |
-
2020
- 2020-05-18 CN CN202010421962.XA patent/CN113683572A/en active Pending
Patent Citations (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1819829A (en) * | 2003-07-07 | 2006-08-16 | 纽罗克里生物科学有限公司 | Pyrimidine-2, 4-dione derivatives as gonadotropin-releasing hormone receptor antagonists |
| US20110098472A1 (en) * | 2007-11-07 | 2011-04-28 | Neurocrine Biosciences, Inc. | Processes for the preparation of uracil derivatives |
| US20180346428A1 (en) * | 2007-11-07 | 2018-12-06 | Helen Chou | Processes for the preparation of uracil derivatives |
| CN108586359A (en) * | 2018-06-26 | 2018-09-28 | 杭州科巢生物科技有限公司 | A kind of synthetic method for disliking La Geli |
| US20200024239A1 (en) * | 2018-07-23 | 2020-01-23 | Abbvie Inc. | Elagolix Sodium Compositions and Processes |
| CN110669014A (en) * | 2019-11-14 | 2020-01-10 | 重庆医药高等专科学校 | Preparation method of oxalagogri intermediate |
| CN110759870A (en) * | 2019-12-06 | 2020-02-07 | 上海博璞诺科技发展有限公司 | Synthesis method of oxalagogri intermediate |
Non-Patent Citations (1)
| Title |
|---|
| 段希焱主编: "《有机合成反应及路线设计研究》", 30 September 2019, 中国原子能出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114195799B (en) | Pyrazine derivatives and their application in inhibiting SHP2 | |
| US4983608A (en) | N-substituted-4-pyrimidinamines and pyrimidinediamines | |
| ES2905973T3 (en) | Process for the preparation of 5-chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine dihydrochloride -2,4-diamine | |
| CN101490040B (en) | 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial | |
| CN101918391B (en) | Some 2-pyrazinone derivatives and their use in preparing inhibitors of neutrophile elastase | |
| CN107207519B (en) | The preparation method of ibrutinib | |
| HU199867B (en) | Process for production of 5-substituated pirimidin nucleosides | |
| EP1309594A1 (en) | Benzimidazole derivatives, preparation and therapeutic use thereof | |
| CN101747282A (en) | Phenyl pyrimidone compounds, pharmaceutical compositions and preparation methods and uses thereof | |
| HU200337B (en) | Process for producing substituted 6-phenyldihydro-3/2h/-pyridazinone derivatives and pharmaceutical compositions comprising such compounds | |
| WO2024099440A1 (en) | Fused ring compound, use thereof, and pharmaceutical composition containing same | |
| CN114478522B (en) | A kind of pyridoimidazole derivatives and its preparation method and application | |
| CN113683572A (en) | Intermediate of oxadegril and preparation method and application thereof | |
| US5179204A (en) | N-substituted-4-pyrimidinamines and pyrimidinediamines | |
| WO2009007747A2 (en) | Hydantoin derivatives used as mmp12 inhibitors | |
| JPH03209393A (en) | Synthesis of 1-(3-azide-2, 3-dideoxy-beta- d-erythropentfuranosil) thymine and its related compound | |
| JPS59118775A (en) | Aralkyltriazole compound | |
| CN102125578B (en) | Phleemycin analog with anticancer activity and synthesis method | |
| Suwiski et al. | Salts of 5-Substituted Uracils with 1, 8-Diazabicyclo [5.4. 0]-undec-7-ene: Convenient Reagents for Nucleophilic Addition and Substitution Reactions | |
| CN102898489B (en) | Phleemycin analog with anticancer activity and synthesis method | |
| JPH05345777A (en) | 7- (4,4-dialkyl-3-amino-substituted pyrrolidinyl) quinolone-3-carboxylic acid derivative | |
| CN111943853B (en) | Preparation method of pezopanib impurity | |
| JP2664837B2 (en) | Trifluorothymidine derivative, process for producing the same, and anticancer agent containing the same as active ingredient | |
| CN112300081A (en) | Intermediate of oxadegril and preparation method and application thereof | |
| JPH10298194A (en) | 2-deoxy-3-ethynyl-β-D-ribofuranosyl derivative |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20211123 |
|
| WD01 | Invention patent application deemed withdrawn after publication |




























































































